• Gemini QACs and Broad-Spectrum Biocidal Design

  2026-09-14

  The 2024 Bioorganic Chemistry study synthesized 16 octenidine-inspired gemini quaternary ammonium compounds and identified structural patterns associated with antibacterial, antifungal, antibiofilm, and virucidal activity. Its most informative results came from balancing cationic architecture, polarity, solubility, cytotoxicity, and spectrum rather than optimizing antimicrobial potency alone.

• Nebivolol Hydrochloride in β1 Signaling

  2026-09-14

  Nebivolol hydrochloride provides a nanomolar, selective β1-adrenoceptor antagonist tool for separating cardiac receptor signaling from broader pathway effects. This workflow also uses the drug-sensitized yeast mTOR platform as an orthogonal counter-screen, helping researchers interpret a negative TOR result without mistaking it for evidence of receptor inactivity.

• EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide

  2026-09-13

  Build more controlled CRISPR-Cas9 genome editing workflows with transient, capped Cas9 mRNA rather than a continuously expressed nuclease. This guide connects Cap1 and m1Ψ chemistry with practical delivery, timing, specificity assays, and troubleshooting in mammalian cells.

• Chlorin e6 (Ce6): Reliable PDT Assay Design

  2026-09-12

  Learn how Chlorin e6 (Ce6), SKU B8314, can improve control of light-dependent cytotoxicity, stock preparation, and mechanistic interpretation in cell assays. This scenario-based guide connects product specifications with published evidence on reactive oxygen species generation, apoptosis, pyroptosis, and anticancer photodynamic therapy.

• PrLGlu/avBNSTGABA Circuit in Depression-Like Behavior

  2026-09-11

  The reference study identifies a projection-defined prelimbic cortex to anterior ventral BNST circuit that rapidly reduces depression-like behaviors in male mice when activated. Its combination of causal circuit manipulation, AMPAR pharmacology, and ketamine-sensitive activity measurements links circuit function to rapid antidepressant mechanisms while also defining important limits for translation.

• Targeting Fructose Metabolism in Cancer

  2026-09-11

  The 2025 Cancer Letters review positions fructose metabolism as a metabolic and signaling dependency associated with aggressive cancer phenotypes. By integrating transporter biology, the endogenous polyol pathway, cancer statistics, and therapeutic concepts, it provides a framework for studying fructose use as a potential vulnerability rather than treating it as a secondary nutrient effect.

• Plerixafor (AMD3100): An Assay-First CXCR4 Guide

  2026-09-10

  Explore how Plerixafor (AMD3100) can function as a mechanistic benchmark for CXCR4 and CXCL12 research. This assay-first guide connects receptor pharmacology with cancer metastasis inhibition, stem cell mobilization, and interpretation of emerging CXCR4 inhibitors.

• Selective Autophagy Tunes IRF3 Stability and IFN

  2026-09-10

  Wu and colleagues show that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus-load-dependent manner, while PSMD14 preserves basal IRF3 through deubiquitination of a K27-linked ubiquitin signal at lysine 313. The work connects ubiquitin editing, autophagic cargo selection, and type I interferon output, providing a mechanistic explanation for how antiviral signaling is restrained without being eliminated.

• Guanabenz Acetate in GPCR Research

  2026-09-09

  Guanabenz Acetate enables subtype-resolved α2-adrenergic receptor experiments with a practical DMSO-based workflow. This guide connects receptor pharmacology to a carefully bounded, hypothesis-driven assay strategy inspired by SARS-CoV-2 stress-granule research.

• Capsazepine Workflows for TRPV1 Research

  2026-09-09

  Capsazepine is a practical pharmacological probe for separating TRPV1-dependent calcium signaling and nociception from downstream inflammatory effects. This guide connects concentration-aware channel assays with pain-model controls, TRPM8 selectivity checks, and exploratory apoptosis sensitization studies.

• Sorafenib in Liver Cancer Research Workflows

  2026-09-08

  Build reproducible Sorafenib workflows for RAF/MEK/ERK signaling, tumor proliferation inhibition, and angiogenesis studies in liver cancer models. This guide also shows how to use Sorafenib as a mechanistic benchmark alongside mitochondrial cholesterol and mitophagy assays inspired by recent celastrol research.

• A1 and CXCR4 Inhibition in Colorectal Cancer

  2026-09-08

  Khorramdelazad et al. evaluate A1, a fluorinated CXCR4 inhibitor, through molecular dynamics, CT-26 cell experiments, and a BALB/c colorectal cancer model. A1 showed more favorable calculated CXCR4 binding than AMD3100 and produced stronger effects on tumor growth, migration, regulatory T-cell infiltration, and immunosuppressive signaling in vivo, while remaining a preclinical candidate requiring further validation.

• Guanabenz Acetate in Receptor and Stress Assays

  2026-09-07

  Guanabenz Acetate provides a subtype-aware way to perturb α2-adrenergic signaling while monitoring stress-granule and innate-immune phenotypes. This workflow connects receptor pharmacology with the GADD34–IRF3 biology reported in SARS-CoV-2 research, while clearly separating established evidence from testable assay hypotheses.

• AO/PI Staining Solution for Accurate Cell Counting

  2026-09-07

  AO/PI Staining Solution uses two fluorescent DNA dyes to distinguish cells with intact membranes from cells with compromised membranes. The K2269 reagent supports fluorescence-based cell counting and can reduce debris and red-blood-cell interference when the workflow is validated with appropriate controls.

• Phillygenin in Diabetic Nephropathy: Mechanistic Evidence

  2026-09-05

  The reference study shows that phillygenin protects against diabetic kidney injury in high-glucose podocytes and db/db mice by suppressing TLR4/MyD88/NF-κB-associated inflammation and supporting PI3K/AKT/GSK3β signaling. Its integrated use of RNA sequencing, cellular assays, biochemical readouts, histology, and animal studies provides a useful preclinical framework for connecting podocyte apoptosis with albuminuria.

7939 records 1/530 page Next 12345 下5页 Last page